Infants at risk for autism: a European perspective on current status, challenges and opportunities by Bolte, S et al.
 1 
 
Infants at risk for autism: 
A European perspective on current status, challenges and opportunities 
 
Sven Bölte
1
, Peter B. Marschik
2
, Terje Falck-Ytter
1,3
, Tony Charman
4
, Herbert Roeyers
5
, 
Mayada Elsabbagh
6,7
 
for the members of the COST action BM1004 work groups 1 and 2*
 
 
1
Department of Women’s and Children’s Health, 
Center of Neurodevelopmental Disorders at Karolinska Institutet, Stockholm, Sweden 
2
Institute of Physiology, Center for Physiological Medicine, 
Medical University of Graz, Austria 
3
Babylab, Department of Psychology, Uppsala University, Sweden 
4Institute of Psychiatry, King’s College London, London, UK 
5
Department of Experimental Clinical and Health Psychology, Ghent University, Belgium 
6
Centre for Brain and Cognitive Development, Birkbeck College, University of London, UK 
7
Department of Psychiatry, Montreal Children's Hospital, Montreal, Canada 
*[these authors should be listed in the articles’ acknowledgements, with their names connected to the article in 
Pubmed] Christa Einspieler (Austria); Petra Warreyn (Belgium); Markéta Havlovicová, Michal Hrdlicka, Iva 
Dudova (Czech Republic); Anneli Kylliainen, Eija Karna (Finland); Catherine Barthelemy, Marie Gomot 
(France); Luise Poustka, Judith Sinzig (Germany); Agnes Kovacs, Ernő Téglás, Gyorgy Gergely (Hungary); 
Louise Gallagher (Ireland); Fabio Apicella, Teresa Farroni, Filippo Muratori (Italy); David Mankuta, Nurit 
Yirmiya (Israel); Vladimir Trajkovski, Silvana Markovska-Simoska (Macedonia); Chantal Kemner, Jan 
Buitelaar (Netherlands); Claes von Hofsten (Norway); Astrid Vicente, Guiomar Oliveira (Portugal); Aurora 
Arghir, Magdalena Budisteanu, Andrei Miu (Romania); Andreas Mueller (Switzerland), Ricardo Canal, Patricia 
Garcia-Primo, Manuel Posada (Spain); Simon Baron-Cohen (UK). 
 
Corresponding author: Professor Sven Bölte, PhD, Department of Women’s and Children’s 
Health, Center of Neurodevelopmental Disorders at Karolinska Institutet (KIND), Astrid 
Lindgren Children’s Hospital, Q2:07, 17176 Stockholm, Sweden; sven.bolte@ki.se 
Tel.: +46 8 51777914, Fax: +46 8 51779696  
 2 
Abstract 
Currently, autism cannot be reliably diagnosed before the age of two years, which is why 
longitudinal studies of high-risk populations provide the potential to generate unique 
knowledge about the development of autism during infancy and toddlerhood prior to 
symptom onset. Early autism research is an evolving field of child psychiatric science. Key 
objectives are fine mapping of neurodevelopmental trajectories and identifying biomarkers in 
order to improve risk assessment, diagnosis and treatment. ESSEA (Enhancing the Scientific 
Study of Early Autism) is a COST (European Cooperation in Science and Technology) Action 
striving to create a European collaboration to enhance the progress of the discovery and 
treatment of the earliest signs of autism, and to establish European practice guidelines on 
early identification and intervention by bringing together European expertise from cognitive 
neuroscience and clinical sciences. The objective of this article is to clarify the state of current 
European research on at risk autism research, and to support the understanding of different 
contexts in which the research is being conducted. We present ESSEA survey data on ongoing 
European high risk ASD studies, as well as perceived challenges and opportunities in this 
field of research. We conclude that although high risk autism research in Europe faces several 
challenges, the existence of several key factors (e.g. new and/or large scale autism grants, 
availability of new technologies, and involvement of experienced research groups) lead us to 
expect substantial scientific and clinical developments in Europe in this field during the next 
years. 
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Introduction 
Autism Spectrum Disorders (ASD) are neurodevelopmental disorders defined by impairments 
across the areas of reciprocal social interaction, verbal and non-verbal communication, 
alongside a preference for repetitive, stereotyped activities, patterns of behaviors and interests 
[3]. Most of the traditional clinical and basic science literature on ASD focused on the 
phenomenon at the age between four and five years. Indeed, until some 10 years ago, it was 
fairly uncommon for children to get diagnosed with autism before the age of three or four 
years. Even in today’s clinical practice, in many cases, especially milder variants of ASD, late 
ASD diagnoses frequently occur. This is despite the fact that both major diagnostic systems 
(DSM-IV-TR, ICD-10) in their editions published in the early to mid-90s defined an early-
onset of symptoms (<36 months of age) as essential for classical autism. In addition, the 
concept of ASD in general implies pervasive developmental delay and/or deviance in a 
multitude of basic functions, such as play, motor development, attention, adaptive behavior, 
particularly social reciprocity and verbal as well as nonverbal communication being apparent 
from early childhood onwards. Also, most parents are concerned about their children’s 
behavior from early on. In a study by Chawarska et al. [5] the average age of first parental 
concerns was 14 months. On the other hand, there is a substantial minority of autistic 
individuals who develop typically or apparently typically at first (up to 24 months of age), but 
later show a loss of skills and developmental regression [15]. Furthermore, the symptom 
severity in ASD is variable, as are socio-communicative, speech-language and intellectual 
skills, and children with ASD might present with striking co-existing problems unspecific to 
ASD (e.g., irritability, hyperactivity, sleep and feeding problems) or may typically developing 
to the non-experienced or untrained observer. Hence, adequate early ASD detection in infants 
is challenging. 
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In recent years, a growing interest in infant development and early detection of ASD 
has emerged, mostly driven by the insight that early identification is a prerequisite for early 
intervention, which itself may improve long-term outcomes for individuals with ASD [6]. 
Several methodologies have helped to study early detection and examine early development 
in ASD. Screening instruments for early signs of ASD, such as the Checklist for Autism in 
Toddlers (CHAT), Early Screening for Autistic Traits, the Modified-CHAT, and the Infant 
Toddler Checklist (ITC) have demonstrated the possibility to prospectively identify ASD at 
18 months or even earlier (for reviews see [1, 4]) in low-risk and high-risk populations. 
Common early signs are primarily delays and deficits in response to name and joint attention 
and limited or perseverative early play. Nevertheless, many of these signs are neither specific 
for nor universal to ASD, with low positive predictive values, and a risk for overreferral 
particularly in case of one stage screening. Another method to study early development in 
ASD is retrospective analyses of home videos collected prior to diagnosis. Palomo, 
Belinchón, and Ozonoff [19] summarized eight such studies from the first two years of life of 
children who were later diagnosed with ASD. Consistent early signs in the first year of life 
were reduced response to name as well as reduced frequency of looking at faces. During the 
second year of life pointing to request and to show, as well as showing/giving objects were 
the most prominent atypical features. 
To focus on the early development and early detection of autism, an alternative and 
increasingly applied approach is the longitudinal study of infant siblings of children with 
ASD. Infant siblings are at increased risk (~20%) of developing ASD compared to 1% of the 
general population, with the risk being higher for males than for females, and higher for those 
from multiplex (>1 sibling) then simplex families [18]. By monitoring developmental 
trajectories in high-risk siblings more precise information about the first appearance of 
autistic behaviors has evolved (for reviews, see [20, 25, 27]). A note of caution is that it is a 
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matter of debate whether ASD aetiologies are comparable between simplex and multiplex 
families with ASD [14], so there may be limits on the extent to which findings from infant 
sibling studies generalize to the simplex population. High-risk studies consistently reported 
that while infants later diagnosed with ASD exhibit signs of the condition at 12 months (e.g., 
lack of eye contact, reciprocal smiling, and social engagement), no such behavioral 
differences have been reliably detected at 6 months [17]. Nevertheless, the search for 
behavioral and biological markers with sufficient sensitivity and specificity to be of clinical 
feasibility and validity using a multitude of techniques (e.g. questionnaires, behavioral 
observation, eye-tracking, magnetic resonance imaging (MRI), event related potentials 
(ERPs)) in high-risk autism populations is an ongoing quest. Most recent evidence from eye-
tracking studies, including those from ESSEA laboratories (Enhancing the Scientific Study of 
Early Autism), suggests that subtle joint attention difficulties at 13 months might be related to 
ASD or other altered neurodevelopmental outcomes [2], and that children with poor social 
and communicative skills differ from typically developed concerning eye gaze patterns 
leading to successful word learning [12]. On the other hand, decreased in a recent US study 
eye contact in high-risk siblings at 6 months was not related at all to ASD outcome at 24 
months [16, 26]. Parent-infant interaction observations in 6- to 10 month-old infants found 
less liveliness in the at risk sample, and more directedness as well as lower sensitive 
responsiveness of their parents, compared to low-risk controls [21]. Interestingly, two 
independent studies [22, 23] suggest that some of the earliest risk markers may lie within the 
motor domain. With respect to electrophysiological evidence, Elsabbagh et al. [8] using ERPs 
in found response to dynamic eye gaze shifts during the first year (6 to 10 months of age) 
were associated with autism diagnosed at 36 months. Other neuroimaging work from the US 
Infant Brain Imaging Study (IBIS) network using diffusion tensor imaging found aberrant 
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white matter fiber tract at 6 months and subsequent tract trajectories to be associated with and 
ASD diagnosis at 24 months [24]. 
Generally, enhanced collaboration and networking must be viewed crucial in moving 
forward with challenging scientific questions in early autism research. There is a need for 
sharing protocols and data between labs to advance practice and influence policy makers. 
While consortia like the IBIS and Baby Sib Research Consortium (BSRC) are ongoing in 
North America, until recently a comparable and competitive coherent Europe-wide network 
has not yet been established. ESSEA (for details please see http://www.cost-essea.com/) is a 
COST (European Cooperation in Science and Technology) Action striving to establish an 
interdisciplinary scientific network to advance the pace of discovery about the earliest signs of 
autism; to combine techniques from cognitive neuroscience with those from the clinical 
sciences; and to generate European practice guidelines on early identification and 
intervention. ESSEA is funded under the EU’s Seventh Framework Programme for Research 
(FP7) via the European Science Foundation (2011-2014). It is a network of over 60 scientists 
from 22 European countries and various scientific disciplines. COST is a means for European 
researchers to jointly develop new ideas and initiatives across scientific disciplines through 
trans-European networking of nationally funded research activities. COST provides financial 
support only for joint activities such as conferences, short-term scientific exchanges, training 
schools and publications. ESSEA intends to develop European capacity in early autism 
research. The lack of a forum to enhance the scientific synergies between these strands of 
basic and applied research has previously hindered progress. Increased and earlier recognition 
has impacted across Europe in terms of demand for diagnostic services and interventions. 
Current health care systems across Europe are very variable in terms of their expertise and 
capacity to support families with young children with autism, often leading to 
marginalization. Although the primary focus of ESSEA is research it offers options to help 
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build capacity for health systems and clinical care (e.g. raise awareness, spread expertise, 
provide research to practice solutions, and propose evidence-based clinical guidelines).  
The goal of this article is to review European research capacities in the field of at risk 
for ASD research and to support the understanding of differences in European research 
contexts. The findings might be valuable to overcome research impediments, and to highlight 
how using specific strengths of the European collaborative sites might be used to this effect, 
as well as to raise awareness and possibly influence public policy towards greater engagement 
in ASD issues in Europe. For this purpose, two surveys were sent to members of ESSEA 
actively involved in high risk research and/or in the development of novel methods for early 
autism research (WG1 and WG2 members): firstly, one on ongoing full scale, pilot, as well as 
planned high-risk studies in Europe among ESSEA sites; and secondly, another on perceived 
challenges and opportunities for autism research in general and high-risk research in 
particular among those European research sites. 
 
Methods 
Instruments 
High-risk studies and applied technologies. For the survey of ESSEA members' ongoing or 
planned high-risk autism studies, and applied technologies, ESSEA member principal 
investigators completed an open item format investigator questionnaire. It inquired about 
ongoing or planned research projects, methodologies, technologies, collaborative attitudes, 
priorities, collaborators, interests, funding, and relevant publications in early autism research. 
For researchers currently or soon to start conducting research with populations at risk for 
autism (investigators involved in collaborative projects to complete the survey jointly) the 
survey required information on: the status, principal investigators, project title, current sample 
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size, project’s total sample size, key words for focus of study, type of risk sample, 
methodologies and technologies employed, and project start. 
Barriers and opportunities. For the mapping of existing, experienced, and perceived 
circumstances that may hamper (“barriers”) or may strengthen (“opportunities”) progress in 
research and cooperation in the area of autism in general and high-risk studies in particular on 
a national and European basis a 25 item questionnaire using a closed format was developed. It 
explores funding, recruitment, awareness, traditions, cooperation with public and interest 
organizations, ethics, and the availability of instruments/methods, and qualified personnel. It 
contains 20 questions on barriers and 5 on opportunities (see Table 2). For each barrier or 
challenge item respondents needed to quantify, whether the specific issue inquired about 
posed no, a mild, a moderate, or severe barrier. For each opportunity, respondents evaluated 
whether the specified issue had no, minor good, or excellent potential within their research 
environment. 
 
Participants, procedure and analyses 
Eighteen sites from 17 European countries completed the initial mapping of studies and 
technologies between January and March 2011: UK, Ireland, Hungary, Belgium, Spain, 
Sweden, The Netherlands, Finland, France, Norway, Romania, Italy, Macedonia, Czech 
Republic, Portugal, Germany, and Israel (2 sites). The surveys were sent via e-mail to the 
principal investigators or research groups’ contact persons, and returned electronically. The 
returned material was analyzed, and summarized to form an overview on studies and 
technologies with high-risk autism research. Countries without ongoing or planned high-risk 
studies were excluded. Finally, the overview was sent to the informants for approval. Before 
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submission (August 2012) of this article some numbers were updated in this overview, 
particularly the current N of enrolled participants. 
With regards to the mapping exercise on barriers and opportunities 16 sites from 15 
countries responded between October 2011 and February 2012: UK, Ireland, Belgium, Spain, 
Sweden, The Netherlands, France, Romania, Italy, Macedonia (2 sites), Czech Republic, 
Portugal, Austria, Germany, and Israel. In cases where clarification was needed to complete 
the questionnaire, these issues were discussed during the regular WGs telephone conferences, 
or via e-mail. Questionnaire data were entered in SPSS 19, and analyzed descriptively on item 
level for frequency distribution of scores. To avoid bias towards one specific European 
country and because the pattern of responses were similar, the data from the two Macedonian 
sites was collapsed to one. 
 
Results 
High-risk studies and applied technologies 
An overview on the relevant projects is given in Table 1. In four countries full scale studies 
on high-risk autism populations are currently conducted: in the UK, the Baby Sibling Study 
network (BASIS; basisnetwork.org) headed by the Centre for Brain and Cognitive 
Development at Birkbeck University; in Belgium, at Ghent University, Department of 
Experimental Clinical and Health Psychology, Research group Developmental Disorders 
(Baby Study; ontwikkelingsstoornissen.ugent.be/babystudie); in Sweden, the Early Autism 
Sweden Study (EASE, earlyautism.se) at Karolinska Institutet, Department of Women’s and 
Children’s Health (KIND) and Uppsala University, Department of Psychology (Babylab); as 
well as in Italy, at Padua University. Participants also reported that pilot and planned studies 
are ongoing in the Czech Republic, Israel, Portugal, and Spain. A substantial body of 
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literature on the high-risk autism field is already available from some of these groups (e.g. [4-
10]). Populations examined are in the majority autism siblings, but also preterm babies. The 
Swedish site also aims to include children with fetal alcohol syndrome and neonatal 
abstinence syndrome. The target N for at-risk siblings/pre-term infants of the studies varies 
between 12 and 300, with the BASIS network currently having enrolled most high-risk 
children and low-risk controls (n~200). Applied assessments range from behavior and 
neurobiology/neurophysiology to genetics. Among the technologies applied in infants are 
(quantitative) EEG, ERP, eye tracking, functional Near-Infrared Spectroscopy (fNIRS), 
structural MRI, functional MRI, diffusion tensor imaging, copy number variants analysis, and 
comparative genomic hybridization-arrays. 
 
About here: Table 1 
 
Barriers and opportunities 
Detailed findings are shown in Table 2. Almost three-quarters of the responding sites report 
mild to moderate barriers in the areas of funding high-risk research and recruiting adequate 
samples and sample sizes. More than sixty percent mentioned mild to severe problems when 
contacting and trying to collaborate with public organizations (e.g., preschool, health care). 
Stigmatization surrounding autism was perceived as a mild to severe problem in over 40% of 
the responding countries, while in only one country lacking cooperation of interest and parent 
organizations was perceived as a severe challenge. Autism awareness was judged to be low by 
almost half of the countries. A more general anti-psychiatry sentiment, and certain traditions 
(“psychosocial”, “humanistic”, “psychoanalytic”) were also experienced to moderately or 
severely hamper autism research by half of the respondents. In addition, 40% or more of 
respondents reported challenges concerning the availability of adequate diagnostic 
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instruments, qualified personnel, or getting ethical approval. Finally, more than 20% reported 
other challenges not explicitly covered by the survey, such as interdisciplinary cooperation 
(e.g. with obstetrics and neonatology), conducting longitudinal research, educational 
prerequisites, and more specific issues with regard to the standardization and validation of 
psychometric tools. When members of participating ESSEA countries were asked about 
strengths and possibilities for autism and high-risk research, >20% reported good to excellent 
funding, each 30 to 40% recruitment and personnel, and >50% collaboration with interest 
organizations. 
 
About here: Table 2 
 
Discussion 
Researchers from seventeen different European countries contributed to our surveys, 
suggesting that our results are fairly representative of the situation in Europe regarding 
research on autism early in life. Our surveys identified a number of unique strengths. Studies 
on high-risk for autism populations and the use of novel technologies are evolving in Europe. 
Despite the relatively small number of studies, current projects range from large-scale 
collaborative initiatives to small pilots, and planned projects. Current high-risk populations 
under investigation are infant siblings of children with ASD, preterm infants, as well as 
individuals with neonatal abstinence syndrome and fetal alcohol syndrome. Areas of expertise 
include genetics, neurolinguistics, neuroscience, developmental science and clinical research. 
Applied technologies are equally broad, and include eye tracking, ERP/EEG, MRI, and 
fNIRS. Particularly with the BASIS network in the UK, Europe has demonstrated interest in 
the field, and established an internationally recognised cohort study, and other groups are 
catching up. Moreover, about 20 to 50% of the respondents reported moderate to excellent 
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opportunities for research funding, recruitment of infants, employment of adequately educated 
personnel, and cooperation with parent, and interest organizations. Finally, initiatives such as 
COST facilitate interaction between sites through specific mechanisms such as lab exchanges, 
training schools, enhanced communication etc. Against this background, there seems to be a 
good potential to further develop at risk research and collaboration in Europe to advance the 
pace of change in basic and clinical science relative to early autism in the coming years.  
We also identified substantial challenges for high-risk autism research and usage of 
technologies in Europe. Aside from funding and recruitment problems, a majority mentioned 
limited support by public organizations (e.g., preschool, health care). Also, stigmatization of 
children with autism, low autism awareness, anti-psychiatry opinions, limited availability of 
adequate diagnostic instruments and qualified personnel, or getting ethical approval as well as 
predominating traditions with low scientific or empirical background still prevent a better 
situation for high-risk research in many parts of Europe. Information on these impediments 
may serve as a starting point for additional in-depth examination of such challenges, as well 
as to inform national and European organizations with an interest in autism and autism 
research and health care policy makers. Moreover, the ESSEA network may help to eliminate 
these barriers, through active dissemination of the present results on the situation in Europe to 
the public, generating proposed European guidelines for ethical management, and develop 
standards and recommendations for responsible and effective communication of scientific 
evidence and opportunities. 
ESSEA is a potentially powerful initiative to improve the situation for early autism 
research in Europe. In order to enhance the prerequisites for a large scale research platform in 
Europe, that can compare for instance with the primarily US-based BSRC 
(autismspeaks.org/science/initiatives/high-risk-baby-sibs) or IBIS (ibis-network.org) 
networks, ESSEA will as next steps among other things: explore the feasibilities of a data 
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repository for common standardized measures, standardization of ethical and clinical 
management approaches of European high-risk studies, and identify and agree on common 
measures. Further support and synergies for high-risk autism science in Europe can be 
expected from another European autism research collaboration, the Innovative Medical 
Initiatives project EU-AIMS (www.eu-aims.eu): European Autism Interventions – A 
Multicentre Study for Developing New Medications. This consortium project includes 
multiple European sites conducting high-risk infant studies amongst many other basic science 
and clinically-relevant tasks (clinical infrastructure; outcome measures; education and 
training; biomarkers) that overlap both with regards to objectives and academic centers with 
COST ESSEA. 
An increasing interest and progress in the field of high-risk autism research and usage of 
technology in Europe is apparent. Nevertheless, despite a few pioneer research groups, 
Europe cannot yet compare to the level of experience, expertise, networking and funding 
achieved in North America. With the ESSEA COST Action and the EU-AIMS IMI 
consortium project the European Union has funded initiatives that promise to make European 
research on early autism internationally competitive. The next years will be decisive for 
European autism scientists to convince European funders that this money is well spent, and to 
motivate continued support and funding. 
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Table 1 Summary of ESSEA locations, enrollment numbers, and methodologies 
Status Country Principal 
Investigator(s) 
Project title Current 
N 
Total 
N 
Topic key words  Risk Groups Methodology/Technologies Project 
start 
Ongoing 
Full-scale 
UK M.H. Johnson British Autism Study of 
Infant Siblings (BASIS)-
UK research network 
www.basisnetwork.org 
188 260 Brain, social, 
attention, motor, 
BAP, genetics, 
intervention 
Infant ASD 
siblings 
Genetics, EEG, MRI, behavior, 
eye tracking, standardized 
measures, questionnaires 
2008 
 Belgium H. Roeyers Social cognitive 
mechanisms of 
understanding 
intentional agents in 
typical and atypical 
development 
60 
 
 
 
0 
150 
 
 
 
100 
Social development, 
attention 
Infant ASD 
siblings 
 
 
Preterm 
infants 
EEG, behavior, eye tracking, 
standardized measures, 
questionnaires 
2007 
 
 
 
2012 
 Sweden U. Ådén 
S. Bölte 
Follow up of extremely 
preterm infants at 6 
years- a population 
based study in 
Stockholm (NeoBIC) 
50 117 Brain, cognition Preterm 
infants 
Standardized measures, 
questionnaire, MRI 
2004 
 Sweden S. Bölte 
T. Falck-Ytter 
G. Gredebäck 
 
Early Autism Sweden 
(EASE) 
www.earlyautism.se 
30 
 
 
0 
100 
 
 
30 
Non-verbal 
communication, BAP, 
autonomous system, 
motor function, brain, 
microbiota 
 
Infant ASD 
siblings 
 
Infants with 
fetal alcohol/ 
neonatal 
abstinence 
syndrome 
Eye tracking, MRI, NIRS, 
behavior, standardized 
measures questionnaires 
 
2011 
 
 
TBD 
 Italy T. Farroni Predictors at birth and in 
premature babies 
3 TBD ASD predictors Preterm 
infants 
NIRS, behavioral 2010 
 20 
Pilot Czech 
Republic 
M. Hrdlicka New approaches to early 
diagnostics of autism 
5 12 Genetics ASD siblings Karyotyping, screening, CNV 
analysis 
2011 
 Israel N. Yirmiya Association between 
pre-term birth and ASD 
spectrum disorders and 
the BAP 
25 100 ASD phenotype Preterm 
infants 
Observation, Interview 2009 
 Israel D. Mankuta Prenatal clues for 
Autism in high-risk 
groups 
35 300 Biochemical, 
sonographic, genetic 
markers 
Infant ASD 
siblings 
Ultrasound, amniotic fluid 
analyses 
2012 
Planned Portugal A. Vicente Earliest signs of autism 0 200 Genetics TBD CGH arrays, questionnaires 2012 
 Spain M. Posada 
R. Canal 
Spanish ASD sibling 
cohort: Feasibility study 
0 TBD feasibility, 
epidemiology  
Infant ASD 
siblings 
Screening  2011 
 
Note. TBD = to be determined; BAP = broader autism phenotype. 
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Table 2 Survey results for mapping research barriers (items 1-20) and opportunities (items 21-25) 
among ESSEA members 
 No 
barrier  
 
Mild 
barrier 
 
Moderate 
barrier 
 
Severe 
barrier 
 
 % % % % 
1. There are funding challenges for high-risk 
autism research. 
26,7 13,3 60,0 0 
2. There are funding challenges for autism 
research in general. 
20,0
  
20,0 60,0 0 
3. There are general research funding 
challenges. 
26,7 13,3 33,3 26,7 
4. There are general challenges in recruiting any 
high-risk sample (e.g. sibs, preterms). 
26,7 13,3 60,0 0 
5. There are challenges in recruiting large 
sample sizes of high-risk subjects.* 
21,4 0 42,9 35,7 
6. Parents are negative/uncooperative towards 
autism research in general.** 
92,3
  
0 0 7,7 
7. Parents are negative/uncooperative towards 
high-risk autism research. 
93,3 0 0 6,7 
8. Parent-/interest organizations are 
negative/uncooperative towards autism 
research in general. 
93,3
 
  
0 0 6,7 
9. Parent-/interest organizations are 
negative/uncooperative towards high-risk 
autism research. 
86,6 0 6,7 6,7 
10. There are challenges in cooperating 
with/getting support from public (private) 
organizations (nursery, school, health care 
etc) for autism research in general.* 
35,7 28,6 28,6  7,1 
11. There are challenges in cooperating 
with/getting support from public (private) 
organizations (nursery, school, health care 
etc) for high-risk autism research.* 
43,0 14,2 35,7 7,1 
12. Autism is stigmatized.* 57,2 21,4 14,3 7,1 
13. Autism awareness is low. 46,7 33,3 20,0 0 
14. There exists an anti-psychiatry sentiment.* 50,0 21,4 14,3 14,3 
15. There are certain traditions (psychoanalytic, 
psychosocial, “humanistic”) that hamper 
autism research. 
53,3 33,3 6,7 6,7 
16. Our country is not perceived as developed 
enough to carry-out research on high-risk 
autism populations. 
93,3 0 0 6,7 
17. There are challenges in obtaining diagnostic 
and research tools (e.g. tests, software, 
apparatus), due to several factors (no 
adaptions available, no shipping, no 
administrative rights to use, etc.). 
60,0 13,3 20,0 6,7 
18. There are difficulties in recruiting adequate 
personnel (e.g. no interest, no education, 
place is too expensive for academic salaries, 
insufficient English language skills). 
60,0 13,3 26,7 0 
19. There are challenges in obtaining ethical 
permission for high-risk research.* 
57,2 28,6 7,1 7,1 
20. There are other autism research barriers, 
particularly with regards to high-risk research, 
that have not been addressed in the survey.** 
76,9 15,4 7,7 0 
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 No 
potential  
Minor 
potential  
 
Good 
potential 
 
Excellent 
potential 
 
 % % % % 
21. There are funding opportunities for autism 
research in general and high-risk autism 
studies in particular.*** 
33,3 41,7 16,7 8,3 
22. There are sample recruitment opportunities 
for autism research in general and high-
risk autism studies in particular.** 
30,8 30,8 38,4 0 
23. There are parent/interest organization 
opportunities for autism research in 
general and high-risk autism studies in 
particular.** 
15,4 23,1 53,8 7,7 
24. There are other societal opportunities (e. g. 
high awareness, trust in research, public 
interest) for autism research in general and 
high-risk autism studies in particular.** 
30,8 46,1 23,1 0 
25. There are opportunities with regards to 
methods, personnel, and ethics for autism 
research in general and high-risk autism 
studies in particular.***  
50,0 8,3 41,7 0 
Note. *N=14, ** N=13, ***N=12 
 
